导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -1.49% | 615/1050 |
| 近一周 | -1.78% | 648/1104 |
| 近一月 | -2.40% | 420/1103 |
| 近一季 | -3.80% | 418/1092 |
| 近半年 | -6.91% | 691/1070 |
| 近一年 | 0.23% | 588/1018 |
| 近两年 | 80.42% | 306/926 |
| 近三年 | 60.86% | 209/834 |
| 成立以来 | 303.70% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-1.41% 583/1070 |
4.05% 628/1101 |
- - |
- - |
| 2025 | 41.48% 302/1065 |
9.91% 149/1014 |
3.99% 361/1038 |
23.87% 487/1050 |
-0.06% 456/1065 |
| 2024 | 15.27% 166/1011 |
3.19% 159/960 |
-5.96% 690/983 |
13.80% 319/991 |
4.38% 155/1011 |
| 2023 | 9.79% 27/952 |
15.49% 49/880 |
1.32% 120/895 |
-4.88% 298/915 |
-1.36% 189/952 |
| 2022 | -1.06% 22/867 |
-3.30% 19/773 |
6.10% 455/806 |
-5.67% 74/845 |
2.22% 315/867 |
| 2021 | 28.50% 80/740 |
6.81% 32/580 |
6.94% 429/659 |
9.55% 70/704 |
2.69% 322/740 |
| 2020 | 43.58% 277/554 |
-3.59% 251/419 |
23.03% 225/466 |
17.01% 102/517 |
3.45% 460/554 |
| 2019 | 48.01% 165/410 |
31.74% 280/1146 |
-1.42% 477/1228 |
0.69% 318/390 |
13.19% 91/410 |
| 2018 | -26.62% 170/349 |
- - |
-7.96% 342/990 |
-9.45% 727/1000 |
-10.79% 366/1080 |
| 2017 | -5.10% 187/285 |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 招商量化精选股票A VS. 东吴新产业精选股票A(580008) |